Efinaconazole

Category: topical

Aliases: Jublia

Pharmacological Mechanism

Triazole topical antifungal — fungal CYP51 inhibitor with optimized nail-keratin penetration. FDA-approved for onychomycosis with higher mycologic cure rate than ciclopirox lacquer. 48-week course for full toenail clearing.

Half-Life (t½)

TD: 24h

Dosing Guidelines

• TD: Typical 10mg (Range: 10 - 10 mg)

Target Organ Systems

• digestive
• integumentary
• immune-hematologic